Navigation Links
Auxilium Pharmaceuticals, Inc. to Present at the Cowen and Company 33rd Annual Healthcare Conference
Date:3/4/2013

pment and commercial rights for XIAFLEX in Japan; and Actelion Pharmaceuticals Ltd has development and commercial rights for XIAFLEX in Canada, Australia, Brazil and Mexico. The sBLA for XIAFLEX for the treatment of Peyronie's disease was submitted to the FDA on November 6, 2012 and has been accepted for standard review with a PDUFA date of September 6, 2013. Additionally, collagenase clostridium histolyticum ("CCH") is in phase II of development for the treatment of Frozen Shoulder syndrome (adhesive capsulitis) and phase II of development for the treatment of cellulite (edematous fibrosclerotic panniculopathy). Auxilium is also developing a high concentration testosterone gel product. Auxilium also has rights to pursue additional indications for CCH.

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995, including statements made with respect to Auxilium's strategy, progress and timing of development programs and related trials, the efficacy of its product candidates, the commercial benefits available to it as a result of its agreements with third parties, future operations, financial position, future revenues, projected costs, prospects, plans and objectives of management and other statements regarding matters that are not historical facts, and involve predictions. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, achievements or prospects to be materially different from any future results, performance, achievements or prospects expressed in or implied by such forward-looking statements. In some cases you can identify forward-looking statements by terminology such as ''may'', ''will'', ''should'', ''would'', ''ex
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Announces Issuance of $350.0 Million of 1.50% Convertible Senior Notes Due 2018
2. Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018
3. Auxilium Pharmaceuticals, Inc. Announces Offering of Convertible Senior Notes Due 2018
4. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
5. Auxilium Pharmaceuticals to Announce Third Quarter 2012 Results and Conduct Conference Call on Wednesday, November 7, 2012
6. Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
7. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
8. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
9. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
10. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
11. Auxilium Pharmaceuticals to Announce First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 18, 2014  Sanguine Biosciences – a biotechnology ... study recruitment – will use its proprietary mobile ... Pfizer Inc. find and recruit people diagnosed with ... members to participate in voluntary research, which will ... and hopefully aid in informing the development of ...
(Date:11/18/2014)... 2014 BioLink 2015, the BioPh & ... co-organized by CCCMHPIE ( China Chamber of ... Health Products), UBM Live and Beijing Yizhuang Biomedical ... at Beijing Yizhuang Biomedical Park.   ... This event will gather 200+ decision makers from biopharmaceutical ...
(Date:11/18/2014)... , Nov. 17, 2014  Nopras Technologies ( ... Stewart B. Rosenberg to the position of ... Rosenberg joins Nopras from Bio-Investigations Ltd., a specialized ... he founded 27 years ago, focused in the ... With undergraduate and graduate degrees in biology, biochemistry, ...
Breaking Medicine Technology:Sanguine's Mobile Application to Assist Recruitment for Pfizer Inc. Chronic Pain Research 2BioLink 2015 Will be Held on Jan 22, 2015, with a Focus on Biopharma Industrial Innovation & International Technology Transfer 2BioLink 2015 Will be Held on Jan 22, 2015, with a Focus on Biopharma Industrial Innovation & International Technology Transfer 3Nopras Technologies Inc. Appoints Director Of Business Development - East Coast Operations 2Nopras Technologies Inc. Appoints Director Of Business Development - East Coast Operations 3
... Lupin Pharmaceuticals, Inc. (LPI) announced today that the ... for the Company,s Abbreviated New Drug Application (ANDA) to ... tablets.  Commercial shipment of the product has commenced. ... mg tablets are the AB-rated generic equivalent of Levaquin, ...
... Therapeutics (NYSE Amex: CXM ) today ... Nuclear Cardiology Core Laboratory (Cedars-Sinai Core Laboratory), Los ... lab for the Company’s Generx ASPIRE clinical study. ... consolidation and analysis of SPECT (single-photon emission computed ...
Cached Medicine Technology:Lupin Announces Launch of Generic Levaquin® Tablets 2Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation 2Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation 3Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation 4Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation 5Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation 6Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation 7
(Date:11/18/2014)... OpenWorks, one of America’s leading commercial cleaning franchises, ... Invitational. The John C. Lincoln Health Foundation holds the ... Mission community programs. Open Works was a Tee Sponsor ... at Camelback Golf Club in Scottsdale. More than 250 ... Mission — including a food bank, children's dental clinic, ...
(Date:11/18/2014)... 2014 As children head back to ... look at fall as the perfect time to refresh ... , Orange County facial plastic surgeon, has observed a ... At the Gallery of Cosmetic Surgery he has noticed ... non-invasive cosmetic surgery procedures. , “Non-invasive cosmetic treatments ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... people on the verge of burning out are more likely ... suffering from so-called vital exhaustion -- a toxic combination of ... risk of developing heart disease, researchers report. "In our ... And I think, when that stress is left unchecked for ...
(Date:11/17/2014)... (PRWEB) November 17, 2014 A Diet ... of patients throughout the country are turning back the ... ever before. This is because the company has recently ... their already impressive collection of prescription and non-prescription diet ... have incorporated Diet Doc’s best anti-aging human ...
(Date:11/17/2014)... 2014 HIPAA Secure Now! was voted ... members of the ASCII Group, a membership-based community of ... handed out at this year’s ASCII Success Summit, recognizing ... to helping their peers grow successful businesses. Winners in ... at the Summit on October 23, 2014 in Atlantic ...
Breaking Medicine News(10 mins):Health News:OpenWorks Sponsors 2014 Lincoln Guild Invitational Golf Tournament Hosted by Scottsdale's Camelback Golf Club 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 3Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 2Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 3Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 2Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 3Health News:The ASCII Group Names HIPAA Secure Now! Esteemed Noble Partner at ASCII Success Summit 2014 2Health News:The ASCII Group Names HIPAA Secure Now! Esteemed Noble Partner at ASCII Success Summit 2014 3
... TUESDAY, July 27 (HealthDay News) -- Taking advantage of recent ... breast cancer, European scientists have analyzed those variants in relation ... with certain variants and for certain tumor types. In ... the most use to scientists in their effort to understand ...
... (July 28, 2010) Errors in diagnosis place a ... system and can be devastating for affected patients. ... of comprehensive and coordinated primary care could potentially address ... researchers from Baylor College of Medicine ( www.bcm.edu ) ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, July ... early run the risk of developing breathing problems compared with ... -- defined as between the 34th and 37th weeks of ... born in the United States, the researchers said. And too ...
... clinical trial offering vascular-targeted photodynamic therapy to patients with ... uses a light-activated drug to deliver light energy waves ... prostate cancer cells. "This minimally invasive ... destroy the cancer without making any incision or causing ...
... the most common childhood psychiatric condition in the ... school on time than students with other mental-health disorders ... study by researchers at the UC Davis School of ... third of students with ADHD, twice the proportion as ...
... quicker and more efficient at implementing surgical safety initiatives ... providing a standard of surgical care that is at ... of care services, according to an 18-month series of ... Department of Surgery. "The quality and standard of ...
Cached Medicine News:Health News:Genetic Risk Score Can Predict Odds For Breast Cancer 2Health News:Reform of primary care could reduce diagnostic errors 2Health News:Reform of primary care could reduce diagnostic errors 3Health News:Reform of primary care could reduce diagnostic errors 4Health News:Delivering Babies Even a Few Weeks Early Ups Respiratory Risks 2Health News:Delivering Babies Even a Few Weeks Early Ups Respiratory Risks 3Health News:NYU Langone offers vascular-targeted photodynamic therapy for localized prostate cancer 2Health News:ADHD, conduct disorder and smoking most strongly related to dropping out of high school 2Health News:ADHD, conduct disorder and smoking most strongly related to dropping out of high school 3Health News:ADHD, conduct disorder and smoking most strongly related to dropping out of high school 4Health News:Smaller hospitals can provide safe and high-quality surgical care comparable to larger counterparts 2Health News:Smaller hospitals can provide safe and high-quality surgical care comparable to larger counterparts 3
Inquire...
Protects skin from corrosive drainage with the standard wear, FlexWear skin barrier. Security and confidence assured with porous tape, internal non-reflux valves, convenient drain valve....
FlexWear is a cross-linked hydrocolloid skin barrier that provides aggressive adherence and is designed for more than one day weartime....
Convenience, Protection, Comfort and Security -- FirstChoice pouches are your product of choice if you are looking for the convenience of a one-piece pouch that is either cut-to-fit or pre-cut to you...
Medicine Products: